Your trusted destination for CME, CPD & Medical Education across the Middle East.
The congress focused on pediatric hematopoietic stem cell transplantation, bone marrow transplantation, gene therapy, and cellular therapies for children with complex hematological and immunological disorders. Topics included transplant practices, emerging therapies, complications, long-term follow-up of transplant survivors, and innovations aimed at improving outcomes in pediatric BMT.
The 4th Emirates Pediatric Bone Marrow Transplant and Gene Therapy Congress brought together pediatric hematologists, oncologists, bone marrow transplant specialists, researchers, nurses, laboratory professionals, and other healthcare providers involved in pediatric transplantation and cellular therapies. The congress focused on advances in pediatric hematopoietic stem cell transplantation (HSCT), bone marrow transplantation, gene therapy, and gene and cellular therapies. Key discussions addressed current practices, emerging innovations, and complex challenges in the management of children with malignant and non-malignant hematological and immunological disorders. The scientific program featured keynote lectures, expert panel discussions, oral presentations, and poster sessions covering developments in pediatric BMT and gene therapy. Particular emphasis was placed on improving transplant outcomes, managing complications, and addressing the long-term health needs of children following transplantation. The program also explored evolving therapeutic approaches and the expanding role of gene and cellular therapies in pediatric medicine. Through international scientific exchange and multidisciplinary collaboration, the congress provided a platform for sharing clinical experience, research findings, and emerging practices in pediatric transplantation.
Exploring the latest protocols and clinical outcomes in pediatric stem cell transplantation.
Strategies for identifying and treating complications following HSCT in children.
Current best practices for selecting donors and optimizing graft success.
Reviewing new gene therapy treatments for pediatric genetic disorders.
The role and efficacy of CAR-T cell therapies in pediatric oncology.
Bridging the gap between laboratory research and bedside application in cell therapy.
Foundational knowledge required for trainees entering the field of pediatric BMT.
Hands-on insights and real-world case discussions for managing pediatric transplant patients.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow